Enoxaparin Sodium Injection
Product Images NDC 68001-641

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 68001-641). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eno0g 0000 01)

Chemical structure diagram of enoxaparin sodium, illustrating repeating disaccharide units with varying substituents indicating the sodium salt forms and acetyl groups as typical for this low molecular weight heparin.*

FDA Label Image

Structural Formula (Eno0g 0000 02)

Chemical structure diagram of enoxaparin sodium, showing key functional groups and molecular framework relevant to the active ingredient in Enoxaparin Sodium injection by BluePoint Laboratories.*

FDA Label Image

Figure 1 (Eno0g 0000 03)

A forest plot chart displaying relative risk comparisons between Enoxaparin Sodium (Enox) and Unfractionated Heparin (UFH) across various patient subgroups. The chart includes subgroup names, patient numbers, relative risk points with confidence intervals, and percentage risk values for both treatments, highlighting reductions in risk for Enoxaparin in conditions like age, sex, infarct location, diabetes status, and treatment timing.*

FDA Label Image

Figure 2 (Eno0g 0000 04)

A hazard distribution function curve comparing Enoxaparin Sodium injection with UFH (unfractionated heparin) over time to death or myocardial reinfarction up to 30 days, with an inset showing data up to 1 year. The chart includes a log-rank test result indicating statistical significance with p-values less than 0.0001 and 0.0111 respectively.*

FDA Label Image

Enoxaparin Inj Multi Dose Carton (Enox Carton Dl)

Packaging label for Enoxaparin Sodium Injection USP 300 mg per 3 mL (100 mg/mL) by BluePoint Laboratories. The label states the injection is for subcutaneous or intravenous use and comes in a 1 x 3 mL multi-dose vial. It includes storage instructions, warnings, dosage form details, manufacturer information, and barcodes.*

FDA Label Image

Enoxaparin Inj Multi Dose Vial Label (Enox Vial Dl)

Label for Enoxaparin Sodium Injection, USP, 300 mg per 3 mL (100 mg per mL) multi-dose vial. The label indicates it is for subcutaneous or intravenous injection and is manufactured for BluePoint Laboratories by Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Nanjing, China. Storage instructions and barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.